Home LiteratureArticle Details
PMID: 9092641 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA.

Nucleic acids research ·Vol. 25 ·No. 6 ·1997-03-15 ·Pages 1289-95

Parks D, Bolinger R, Mann K

Abstract

Redox modulation of wild-type p53 plays a role in sequence-specific DNA binding in vitro . Reduction produces a DNA-binding form of the protein while oxidation produces a non-DNA-binding form. Primer extension analysis reveals that increasing concentrations of reduced p53 result in enhanced protection of the consensus sequence, while increasing concentrations of oxidized p53 confer minimal protection of the consensus sequence. DNA binding by oxidized p53 is, therefore, not sequence-specific. In contrast, there is no observable difference in the binding of oxidized p53 and reduced p53 to double-stranded non-specific or mismatched DNA in gel mobility shift assays. Both forms of p53 bind equally well, suggesting that redox modulation of p53 does not play a role in its binding to non-specific or mismatched DNA. In view of the in vitro evidence that redox state influences the sequence-specific DNA-binding of p53, we have examined the effect of oxidative stress on the in vivo ability of p53 to bind to and transactivate PG13-CAT, a reporter construct containing multiple copies of the p53 consensus binding site linked to the chloramphenicol acetyltransferase gene. Hydrogen peroxide treatment of cells cotransfected with p53 results in a marked decrease in CAT activity, suggesting that oxidation of p53 decreases the ability of the protein to bind to consensus DNA and transactivate target genes in vivo.

MeSH Terms
Animals Binding Sites Cell Line Chloramphenicol O-Acetyltransferase/biosynthesis DNA/chemistry,metabolism DNA Footprinting Deoxyribonuclease I Genes, Reporter Hydrogen Peroxide/pharmacology Mice Oxidation-Reduction Recombinant Fusion Proteins/chemistry,metabolism Spodoptera Substrate Specificity Transcriptional Activation/drug effects Transfection Tumor Suppressor Protein p53/chemistry,metabolism
Chemicals
Recombinant Fusion Proteins Tumor Suppressor Protein p53 DNA Hydrogen Peroxide Chloramphenicol O-Acetyltransferase Deoxyribonuclease I
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Parks D
Biology Department, University of Alaska, 3211 Providence Drive, Anchorage, AK 99508, USA.
Bolinger R
Mann K
References (53)
53 references, click to expand
  1. Rapid "footprinting" on supercoiled DNA.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3078-81 PMID: 3889902
  2. Redox regulation of transcriptional activators.
    Free Radic Biol Med. 1996;21(3):335-48 PMID: 8855444
  3. Three domains in the simian virus 40 core origin orchestrate the binding, melting, and DNA helicase activities of T antigen.
    J Virol. 1990 Feb;64(2):509-18 PMID: 2153220
  4. Redox regulation of fos and jun DNA-binding activity in vitro.
    Science. 1990 Sep 7;249(4973):1157-61 PMID: 2118682
  5. Ras C-terminal processing enzymes--new drug targets?
    Cell. 1991 Apr 5;65(1):1-4 PMID: 2013090
  6. Rapid and preferential activation of the c-jun gene during the mammalian UV response.
    Mol Cell Biol. 1991 May;11(5):2804-11 PMID: 1901948
  7. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.
    EMBO J. 1991 Aug;10(8):2247-58 PMID: 2065663
  8. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity.
    EMBO J. 1992 Feb;11(2):653-65 PMID: 1537340
  9. Formation of stable p53 homotetramers and multiples of tetramers.
    Mol Carcinog. 1992;5(2):102-6 PMID: 1554407
  10. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Mol Cell Biol. 1992 Jun;12(6):2866-71 PMID: 1588974
  11. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Science. 1992 May 8;256(5058):827-30 PMID: 1589764
  12. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Genes Dev. 1992 Jul;6(7):1143-52 PMID: 1628822
  13. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme.
    EMBO J. 1992 Sep;11(9):3323-35 PMID: 1380454
  14. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  15. Regulation of the specific DNA binding function of p53.
    Cell. 1992 Nov 27;71(5):875-86 PMID: 1423635
  16. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents.
    Oncogene. 1993 Feb;8(2):307-18 PMID: 8426740
  17. A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.
    Cancer Res. 1993 Apr 15;53(8):1739-42 PMID: 8467489
  18. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  19. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  20. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  21. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.
    EMBO J. 1993 May;12(5):2005-15 PMID: 8491191
  22. p53-catalyzed annealing of complementary single-stranded nucleic acids.
    EMBO J. 1993 Jun;12(6):2389-96 PMID: 7685274
  23. Activation of the cryptic DNA binding function of mutant forms of p53.
    Nucleic Acids Res. 1993 Jul 11;21(14):3167-74 PMID: 8341590
  24. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro.
    Cancer Res. 1993 Oct 1;53(19):4469-73 PMID: 8402615
  25. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
    Cell. 1993 Nov 19;75(4):765-78 PMID: 8242748
  26. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  27. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  28. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Genes Dev. 1993 Dec;7(12B):2556-64 PMID: 8276238
  29. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  30. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  31. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):23-7 PMID: 7506414
  32. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):413-7 PMID: 8278402
  33. An iron-sulfur center essential for transcriptional activation by the redox-sensing SoxR protein.
    EMBO J. 1994 Jan 1;13(1):138-46 PMID: 8306957
  34. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  35. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  36. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia.
    Mol Cell Biol. 1994 Sep;14(9):5997-6003 PMID: 8065332
  37. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
    Mol Cell Biol. 1994 Sep;14(9):6264-77 PMID: 8065358
  38. Redox-dependent shift of OxyR-DNA contacts along an extended DNA-binding site: a mechanism for differential promoter selection.
    Cell. 1994 Sep 9;78(5):897-909 PMID: 8087856
  39. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress.
    Nucleic Acids Res. 1994 Nov 25;22(23):4884-9 PMID: 7800476
  40. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Cell. 1995 Jan 27;80(2):293-9 PMID: 7834749
  41. Interaction of p53 with its consensus DNA-binding site.
    Mol Cell Biol. 1995 Apr;15(4):2157-65 PMID: 7891710
  42. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia.
    J Natl Cancer Inst. 1995 Jan 18;87(2):117-22 PMID: 7707382
  43. A direct effect of activated human p53 on nuclear DNA replication.
    EMBO J. 1995 May 1;14(9):2099-105 PMID: 7744015
  44. Role of cysteine residues in regulation of p53 function.
    Mol Cell Biol. 1995 Jul;15(7):3892-903 PMID: 7791795
  45. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches.
    Cell. 1995 Jun 30;81(7):1013-20 PMID: 7600570
  46. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.
    Cell. 1995 Jun 30;81(7):1021-9 PMID: 7600571
  47. Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression.
    Mol Cell Biol. 1995 Aug;15(8):4489-96 PMID: 7623839
  48. Negative feedback regulation of wild-type p53 biosynthesis.
    EMBO J. 1995 Sep 15;14(18):4442-9 PMID: 7556087
  49. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9455-9 PMID: 7568153
  50. p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner.
    Mol Cell Biol. 1995 Dec;15(12):6554-60 PMID: 8524220
  51. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
    Nature. 1996 Jan 4;379(6560):88-91 PMID: 8538748
  52. Epitope analysis of the murine p53 tumour suppressor protein.
    Oncogene. 1996 Jun 6;12(11):2461-6 PMID: 8649788
  53. The p53 proto-oncogene can act as a suppressor of transformation.
    Cell. 1989 Jun 30;57(7):1083-93 PMID: 2525423
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
0305-1048
Published
1997-03-15
Pages
1289-95
Language
English
Region
England
NLM ID
0411011
PMCID
PMC146562
Subset
IM
Grants
NCI NIH HHS · CA-60089 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com